Silas Rydant
Biographic Data
| ID | 6774636 |
|---|---|
| NAME | Silas Rydant |
| GIVEN NAMES | Silas |
| FAMILY NAME | Rydant |
| SIGNATURE | RYDANT S |
| AFFILIATIONS | Province of Antwerp |
| ORCID | 0000-0001-8437-7507 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 4 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2023 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
Optimization of the (pharmacotherapeutic) treatment and care of the diabetes type 2 patient in Belgium through multidisciplinary collaboration between general practitioner and community pharmacist
Introduction: Diabetes type 2 is a chronic condition that can lead to devastating micro-and/or macrovascular complications in the long term when not treated properly. This causes decreased health-related quality of life and an increased risk for morbidity and mortality. Despite safe and effective drugs, there are major challenges in the treatment of diabetes type 2: (1) medication adherence, (2) optimizing pharmacotherapy, (3) non-pharmacotherapy…
Interprofessional collaboration between general practitioners and community pharmacists to promote the safe and responsible use of TNF-α-inhibitors
Introduction: Tumor necrosis factor α-inhibitors (TNF-α-inhibitors) are biological disease-modifying anti-rheumatic drugs (bDMARD’s) that are used in the treatment of different immune mediated inflammatory diseases (IMIDs) (eg. rheumatoid arthritis, psoriasis, Crohn’s disease...). TNF-inhibitors are generally well tolerated and safe, but some major challenges remain in the management of TNF-inhibitors. First of all, only specific specialists (rhe…
What role do professional management organizations play in the implementation of Medical-Pharmaceutical Concertation in Belgium
Introduction: Inadequate use of medication (e.g. over-under-or misuse, interactions, wrong dosing...) can lead to potential clinical dangerous situations. Therefore, the risk need to be mitigated. In 2015, the National Institute for Health & Disability Insurance (NIHDI) of Belgium has created a legal and financial framework (Medical-Pharmaceutical Concertation (MPC) to promote and facilitate local concertation between general practitioners (GP) a…
Interprofessional collaboration between general practitioners and community pharmacists to promote the safe and responsible use of direct oral anticoagulants
Introduction: Direct oral anticoagulants (DOAC) are important assets in the prevention and treatment of thrombo-embolic disease due to the unrivalled combination of ease of use, safety and effectiveness compared to other antithrombotic treatments. However, many drug related problems appear while prescribing and/or dispensing DOAC. Different indications exist and different dosages are available. Moreover, dosage adjustments need to be done in seve…
No prominent works on this page.
Optimization of the (pharmacotherapeutic) treatment and care of the diabetes type 2 patient in Belgium through multidisciplinary collaboration between general practitioner and community pharmacist
Introduction: Diabetes type 2 is a chronic condition that can lead to devastating micro-and/or macrovascular complications in the long term when not treated properly. This causes decreased health-related quality of life and an increased risk for morbidity and mortality. Despite safe and effective drugs, there are major challenges in the treatment of diabetes type 2: (1) medication adherence, (2) optimizing pharmacotherapy, (3) non-pharmacotherapy…
Interprofessional collaboration between general practitioners and community pharmacists to promote the safe and responsible use of TNF-α-inhibitors
Introduction: Tumor necrosis factor α-inhibitors (TNF-α-inhibitors) are biological disease-modifying anti-rheumatic drugs (bDMARD’s) that are used in the treatment of different immune mediated inflammatory diseases (IMIDs) (eg. rheumatoid arthritis, psoriasis, Crohn’s disease...). TNF-inhibitors are generally well tolerated and safe, but some major challenges remain in the management of TNF-inhibitors. First of all, only specific specialists (rhe…
What role do professional management organizations play in the implementation of Medical-Pharmaceutical Concertation in Belgium
Introduction: Inadequate use of medication (e.g. over-under-or misuse, interactions, wrong dosing...) can lead to potential clinical dangerous situations. Therefore, the risk need to be mitigated. In 2015, the National Institute for Health & Disability Insurance (NIHDI) of Belgium has created a legal and financial framework (Medical-Pharmaceutical Concertation (MPC) to promote and facilitate local concertation between general practitioners (GP) a…
Interprofessional collaboration between general practitioners and community pharmacists to promote the safe and responsible use of direct oral anticoagulants
Introduction: Direct oral anticoagulants (DOAC) are important assets in the prevention and treatment of thrombo-embolic disease due to the unrivalled combination of ease of use, safety and effectiveness compared to other antithrombotic treatments. However, many drug related problems appear while prescribing and/or dispensing DOAC. Different indications exist and different dosages are available. Moreover, dosage adjustments need to be done in seve…
Context (archaeology (4 works) · Medicine (4 works) · Pharmaceutical Practices and Patient Outcomes (4 works) · Family medicine (3 works) · Business (2 works) · Formulary (2 works) · Incentive (2 works) · Nursing (2 works) · Pharmacy (2 works) · Political science (2 works)